SCHEMBL4907392

SCHEMBL4907392

COC(=O)c1cc(S(=O)(=O)NCCOc2ccc(C3CCCCC3)cc2)ccc1C

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.47
KMT2A Q03164 5/20 0.46
NPSR1 Q6W5P4 1/20 0.43
ALDH1A1 P00352 4/20 0.43
HTT P42858 3/20 0.43
USP2 O75604 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
MEN1 O00255 3/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
LMNA P02545 1/20 0.42
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4903039 0.92 LMNA (0.52) TDP1KMT2ANPSR1ALDH1A1HTT
SCHEMBL4902606 0.81 TDP1 (0.51) TDP1KMT2ANPSR1ALDH1A1HTT
SCHEMBL4906713 0.81 TDP1 (0.59) TDP1KMT2ANPSR1ALDH1A1HTT
SCHEMBL4909535 0.79 TDP1 (0.57) TDP1KMT2ANPSR1ALDH1A1HTT
SCHEMBL4903029 0.78 TDP1 (0.50) TDP1KMT2ANPSR1ALDH1A1HTT
SCHEMBL4907398 0.78 ALDH1A1 (0.42) TDP1KMT2AALDH1A1HTTSMN1; SMN2
SCHEMBL4900726 0.74 KMT2A (0.44) TDP1KMT2AALDH1A1HTTUSP2
SCHEMBL4899834 0.73 LMNA (0.60) TDP1KMT2ANPSR1ALDH1A1HTT
SCHEMBL4900651 0.72 LMNA (0.52) KMT2AALDH1A1HTTSMN1; SMN2LMNA
SCHEMBL4911881 0.72 PHGDH (0.43) TDP1KMT2ANPSR1ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD TDP1 3363/4885KMT2A 3602/4885NPSR1 773/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD TDP1 3653/4885KMT2A 3530/4885NPSR1 735/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD TDP1 3653/4885KMT2A 3530/4885NPSR1 735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.